View Item 

Show simple item record

Anti‐inflammatory effects of β2 adrenergic receptor agonists in experimental acute lung injury
dc.contributor.authorBosmann, Markus
dc.contributor.authorGrailer, Jamison J.
dc.contributor.authorZhu, Ketong
dc.contributor.authorMatthay, Michael A.
dc.contributor.authorSarma, J. Vidya
dc.contributor.authorZetoune, Firas S.
dc.contributor.authorWard, Peter A.
dc.date.accessioned2020-03-17T18:34:01Z
dc.date.available2020-03-17T18:34:01Z
dc.date.issued2012-05
dc.identifier.citationBosmann, Markus; Grailer, Jamison J.; Zhu, Ketong; Matthay, Michael A.; Sarma, J. Vidya; Zetoune, Firas S.; Ward, Peter A. (2012). "Anti‐inflammatory effects of β2 adrenergic receptor agonists in experimental acute lung injury." The FASEB Journal 26(5): 2137-2144.
dc.identifier.issn0892-6638
dc.identifier.issn1530-6860
dc.identifier.urihttps://hdl.handle.net/2027.42/154493
dc.publisherFederation of American Societies for Experimental Biology
dc.publisherWiley Periodicals, Inc.
dc.subject.otheralbuterol
dc.subject.othermacrophages
dc.subject.otherneutrophils
dc.subject.otherJNK
dc.subject.otherformoterol
dc.titleAnti‐inflammatory effects of β2 adrenergic receptor agonists in experimental acute lung injury
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelBiology
dc.subject.hlbtoplevelScience
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/154493/1/fsb2026005038.pdf
dc.identifier.doi10.1096/fj.11-201640
dc.identifier.sourceThe FASEB Journal
dc.identifier.citedreferenceOddera, S., Silvestri, M., Lantero, S., Sacco, O., and Rossi, G. A. ( 1998 ) Down‐regulation of the expression of intercellular adhesion molecule (ICAM)‐1 on bronchial epithelial cells by fenoterol, a beta2‐adrenoceptor agonist. J. Asthma 35, 401 – 408
dc.identifier.citedreferenceShanley, T. P., Schmal, H., Warner, R. L., Schmid, E., Friedl, H. P., and Ward, P. A. ( 1997 ) Requirement for C‐X‐C chemokines (macrophage inflammatory protein‐2 and cytokine‐induced neutrophil chemoattractant) in IgG immune complex‐induced lung injury. J. Immunol. 158, 3439 – 3448
dc.identifier.citedreferenceWarren, J. S., Yabroff, K. R., Remick, D. G., Kunkel, S. L., Chensue, S. W., Kunkel, R. G., Johnson, K. J., and Ward, P. A. ( 1989 ) Tumor necrosis factor participates in the pathogenesis of acute immune complex alveolitis in the rat. J. Clin. Invest. 84, 1873 – 1882
dc.identifier.citedreferenceBennett, B. L., Sasaki, D. T., Murray, B. W., O’Leary, E. C., Sakata, S. T., Xu, W., Leisten, J. C., Motiwala, A., Pierce, S., Satoh, Y., Bhagwat, S. S., Manning, A. M., and Anderson, D. W. ( 2001 ) SP600125, an anthrapyrazolone inhibitor of Jun N‐terminal kinase. Proc. Natl. Acad. Sci. U. S. A. 98, 13681 – 13686
dc.identifier.citedreferenceJohnson, M. ( 1998 ) The beta‐adrenoceptor. Am. J. Respir. Crit. Care. Med. 158, S146 – S53
dc.identifier.citedreferenceMutlu, G. M., and Factor, P. ( 2008 ) Alveolar epithelial beta2‐adrenergic receptors. Am. J. Respir. Cell Mol. Biol. 38, 127 – 134
dc.identifier.citedreferenceFiorentino, D. F., Zlotnik, A., Mosmann, T. R., Howard, M., and O’Garra, A. ( 1991 ) IL‐10 inhibits cytokine production by activated macrophages. J. Immunol. 147, 3815 – 3822
dc.identifier.citedreferenceWhelan, C. J., Johnson, M., and Vardey, C. J. ( 1993 ) Comparison of the anti‐inflammatory properties of formoterol, salbutamol and salmeterol in guinea‐pig skin and lung. Br. J. Pharmacol. 110, 613 – 618
dc.identifier.citedreferenceMatthay, M. A., and Abraham, E. ( 2006 ) Beta‐adrenergic agonist therapy as a potential treatment for acute lung injury. Am. J. Respir. Crit. Care Med. 173, 254 – 255
dc.identifier.citedreferenceManocha, S., Gordon, A. C., Salehifar, E., Groshaus, H., Walley, K. R., and Russell, J. A. ( 2006 ) Inhaled beta‐2 agonist salbutamol and acute lung injury: an association with improvement in acute lung injury. Crit. Care 10, R12
dc.identifier.citedreferenceMutlu, G. M., and Sznajder, J. I. ( 2005 ) Mechanisms of pulmonary edema clearance. Am. J. Physiol. Lung Cell. Mol. Physiol. 289, L685 – L695
dc.identifier.citedreferenceSpoelstra, F. M., Postma, D. S., Hovenga, H., Noordhoek, J. A., and Kauffman, H. F. ( 2002 ) Additive anti‐inflammatory effect of formoterol and budesonide on human lung fibroblasts. Thorax 57, 237 – 241
dc.identifier.citedreferenceScola, A. M., Loxham, M., Charlton, S. J., and Peachell, P. T. ( 2009 ) The long‐acting beta‐adrenoceptor agonist, indacaterol, inhibits IgE‐dependent responses of human lung mast cells. Br. J. Pharmacol. 158, 267 – 276
dc.identifier.citedreferencePerkins, G. D., McAuley, D. F., Richter, A., Thickett, D. R., and Gao, F. ( 2004 ) Bench‐to‐bedside review: beta2‐agonists and the acute respiratory distress syndrome. Crit. Care 8, 25 – 32
dc.identifier.citedreferenceDhingra, V. K., Uusaro, A., Holmes, C. L., and Walley, K. R. ( 2001 ) Attenuation of lung inflammation by adrenergic agonists in murine acute lung injury. Anesthesiology 95, 947 – 953
dc.identifier.citedreferenceBloemen, P. G., van den Tweel, M. C., Henricks, P. A., Engels, F., Kester, M. H., van de Loo, P. G., Blomjous, F. J., and Nijkamp, F. P. ( 1997 ) Increased cAMP levels in stimulated neutrophils inhibit their adhesion to human bronchial epithelial cells. Am. J. Physiol. Lung Physiol. 272, L580 – L587
dc.identifier.citedreferenceSabatini, F., Silvestri, M., Sale, R., Serpero, L., Di Blasi, P., and Rossi, G. A. ( 2003 ) Cytokine release and adhesion molecule expression by stimulated human bronchial epithelial cells are downregulated by salmeterol. Respir. Med. 97, 1052 – 1060
dc.identifier.citedreferenceQueen, L. R., Ji, Y., Xu, B., Young, L., Yao, K., Wyatt, A. W., Rowlands, D. J., Siow, R. C., Mann, G. E., and Ferro, A. ( 2006 ) Mechanisms underlying beta2‐adrenoceptor‐mediated nitric oxide generation by human umbilical vein endothelial cells. J. Physiol. 576, 585 – 594
dc.identifier.citedreferenceZink, S., Rosen, P., and Lemoine, H. ( 1995 ) Micro‐ and macro‐vascular endothelial cells in beta‐adrenergic regulation of transendothelial permeability. Am. J. Physiol. Cell Physiol. 269, C1209 – C1218
dc.identifier.citedreferenceCobelens, P. M., Kavelaars, A., Vroon, A., Ringeling, M., van der Zee, R., van Eden, W., and Heijnen, C. J. ( 2002 ) The beta 2‐adrenergic agonist salbutamol potentiates oral induction of tolerance, suppressing adjuvant arthritis and antigen‐specific immunity. J. Immunol. 169, 5028 – 5035
dc.identifier.citedreferenceRoux, F. J., Grandordy, B., and Douglas, J. S. ( 1996 ) Functional and binding characteristics of long‐acting beta 2‐agonists in lung and heart. Am. J. Respir. Crit. Care Med. 153, 1489 – 1495
dc.identifier.citedreferenceDonnelly, L. E., Tudhope, S. J., Fenwick, P. S., and Barnes, P. J. ( 2010 ) Effects of formoterol and salmeterol on cytokine release from monocyte‐derived macrophages. Eur. Respir. J. 36, 178 – 186
dc.identifier.citedreferenceAtabai, K., Ware, L. B., Snider, M. E., Koch, P., Daniel, B., Nuckton, T. J., and Matthay, M. A. ( 2002 ) Aerosolized beta(2)‐adrenergic agonists achieve therapeutic levels in the pulmonary edema fluid of ventilated patients with acute respiratory failure. Intensive Care Med. 28, 705 – 711
dc.identifier.citedreferencePerkins, G. D., McAuley, D. F., Thickett, D. R., and Gao, F. ( 2006 ) The beta‐agonist lung injury trial (BALTI): a randomized placebo‐controlled clinical trial. Am. J. Respir. Crit. Care Med. 173, 281 – 287
dc.identifier.citedreferenceMatthay, M. A., Brower, R. G., Carson, S., Douglas, I. S., Eisner, M., Hite, D., Holets, S., Kallet, R. H., Liu, K. D., MacIntyre, N., Moss, M., Schoenfeld, D., Steingrub, J., and Thompson, B. T. ( 2011 ) Randomized, placebo‐controlled clinical trial of an aerosolized beta‐agonist for treatment of acute lung injury. Am. J. Respir. Crit. Care Med. 184, 561 – 568
dc.identifier.citedreferenceLevitt, J. E., Bedi, H., Calfee, C. S., Gould, M. K., and Matthay, M. A. ( 2009 ) Identification of early acute lung injury at initial evaluation in an acute care setting prior to the onset of respiratory failure. Chest 135, 936 – 943
dc.identifier.citedreferenceMatthay, M. A., and Zimmerman, G. A. ( 2005 ) Acute lung injury and the acute respiratory distress syndrome: four decades of inquiry into pathogenesis and rational management. Am. J. Respir. Cell Mol. Biol. 33, 319 – 327
dc.identifier.citedreferenceGoss, C. H., Brower, R. G., Hudson, L. D., and Rubenfeld, G. D. ( 2003 ) Incidence of acute lung injury in the United States. Crit. Care Med. 31, 1607 – 1611
dc.identifier.citedreferenceSakuma, T., Folkesson, H. G., Suzuki, S., Okaniwa, G., Fujimura, S., and Matthay, M. A. ( 1997 ) Beta‐adrenergic agonist stimulated alveolar fluid clearance in ex vivo human and rat lungs. Am. J. Respir. Crit. Care Med. 155, 506 – 512
dc.identifier.citedreferenceSakuma, T., Okaniwa, G., Nakada, T., Nishimura, T., Fujimura, S., and Matthay, M. A. ( 1994 ) Alveolar fluid clearance in the resected human lung. Am. J. Respir. Crit. Care Med. 150, 305 – 310
dc.identifier.citedreferenceTracey, K. J. ( 2009 ) Reflex control of immunity. Nat. Rev. Immunol. 9, 418 – 428
dc.identifier.citedreferenceFlierl, M. A., Rittirsch, D., Nadeau, B. A., Chen, A. J., Sarma, J. V., Zetoune, F. S., McGuire, S. R., List, R. P., Day, D. E., Hoesel, L. M., Gao, H., Van Rooijen, N., Huber‐Lang, M. S., Neubig, R. R., and Ward, P. A. ( 2007 ) Phagocyte‐derived catecholamines enhance acute inflammatory injury. Nature 449, 721 – 725
dc.identifier.citedreferenceDutta, E. J., and Li, J. T. ( 2002 ) Beta‐agonists. Med. Clin. North. Am. 86, 991 – 1008
dc.identifier.citedreferenceSartori, C., Allemann, Y., Duplain, H., Lepori, M., Egli, M., Lipp, E., Hutter, D., Turini, P., Hugli, O., Cook, S., Nicod, P., and Scherrer, U. ( 2002 ) Salmeterol for the prevention of high‐altitude pulmonary edema. N. Engl. J. Med. 346, 1631 – 1636
dc.identifier.citedreferenceMcAuley, D. F., Frank, J. A., Fang, X., and Matthay, M. A. ( 2004 ) Clinically relevant concentrations of beta2‐adrenergic agonists stimulate maximal cyclic adenosine monophosphate‐dependent airspace fluid clearance and decrease pulmonary edema in experimental acid‐induced lung injury. Crit. Care Med. 32, 1470 – 1476
dc.identifier.citedreferenceChen, F., Nakamura, T., Fujinaga, T., Zhang, J., Hamakawa, H., Omasa, M., Sakai, H., Hanaoka, N., Bando, T., Wada, H., and Fukuse, T. ( 2006 ) Protective effect of a nebulized beta2‐adrenoreceptor agonist in warm ischemic‐reperfused rat lungs. Ann. Thorac. Surg. 82, 465 – 471
dc.identifier.citedreferenceMaris, N. A., de Vos, A. F., Dessing, M. C., Spek, C. A., Lutter, R., Jansen, H. M., van der Zee, J. S., Bresser, P., and van der Poll, T. ( 2005 ) Antiinflammatory effects of salmeterol after inhalation of lipopolysaccharide by healthy volunteers. Am. J. Respir. Crit. Care Med. 172, 878 – 884
dc.identifier.citedreferenceBosmann, M., Patel, V. R., Russkamp, N. F., Pache, F., Zetoune, F. S., Sarma, J. V., and Ward, P. A. ( 2011 ) MyD88‐dependent production of IL‐17F is modulated by the anaphylatoxin C5a via the Akt signaling pathway. FASEB J. 25, 4222 – 4232
dc.identifier.citedreferenceBosmann, M., Russkamp, N. F., Patel, V. R., Zetoune, F. S., Sarma, J. V., and Ward, P. A. ( 2011 ) The outcome of polymicrobial sepsis is independent of T and B cells. Shock 36, 396 – 401
dc.identifier.citedreferenceRittirsch, D., Flierl, M. A., Day, D. E., Nadeau, B. A., McGuire, S. R., Hoesel, L. M., Ipaktchi, K., Zetoune, F. S., Sarma, J. V., Leng, L., Huber‐Lang, M. S., Neff, T. A., Bucala, R., and Ward, P. A. ( 2008 ) Acute lung injury induced by lipopolysaccharide is independent of complement activation. J. Immunol. 180, 7664 – 7672
dc.identifier.citedreferenceHuber‐Lang, M., Sarma, J. V., Zetoune, F. S., Rittirsch, D., Neff, T. A., McGuire, S. R., Lambris, J. D., Warner, R. L., Flierl, M. A., Hoesel, L. M., Gebhard, F., Younger, J. G., Drouin, S. M., Wetsel, R. A., and Ward, P. A. ( 2006 ) Generation of C5a in the absence of C3: a new complement activation pathway. Nat. Med. 12, 682 – 687
dc.identifier.citedreferenceGao, H., Neff, T., and Ward, P. A. ( 2006 ) Regulation of lung inflammation in the model of IgG immune‐complex injury. Annu. Rev. Pathol. 1, 215 – 242
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
fsb2026005038.pdf
Size:
320.1KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.